Loading...

Fortress Biotech, Inc.

FBIO•NASDAQ
Healthcare
Biotechnology
$2.48
$0.07(2.90%)
U.S. Market opens in 0h 3m

Fortress Biotech, Inc. (FBIO) Stock Overview

Explore Fortress Biotech, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap79.9M
P/E Ratio0.62
EPS (TTM)$3.23
ROE1.61%
Fundamental Analysis

AI Price Forecasts

1 Month$2.73
3 Months$3.72
1 Year Target$4.14

FBIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Fortress Biotech, Inc. (FBIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.62 and a market capitalization of 79.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.90%
5-Day Change
10.22%
1-Month Change
5.08%
3-Month Change
-28.12%
6-Month Change
-7.12%
Year-to-Date (YTD) Change
-32.24%
1-Year Change
40.91%
3-Year Change
-67.58%
5-Year Change
-95.59%
All-Time (Max) Change
-98.50%

Contact Information

https://www.fortressbiotech.com
781 652 4500
1111 Kane Concourse, Bay Harbor Islands, FL, 33154

Company Facts

101 Employees
IPO DateNov 17, 2011
CountryUS
Actively Trading

Frequently Asked Questions